IRIS
MATERA, Maria Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.859
NA - Nord America 7.274
AS - Asia 7.061
SA - Sud America 1.484
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 26.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.180
RU - Federazione Russa 4.290
SG - Singapore 2.927
IE - Irlanda 1.958
HK - Hong Kong 1.473
CN - Cina 1.389
BR - Brasile 1.276
UA - Ucraina 1.120
GB - Regno Unito 867
IT - Italia 791
DE - Germania 742
VN - Vietnam 338
FI - Finlandia 289
KR - Corea 264
FR - Francia 252
GR - Grecia 221
SE - Svezia 191
TR - Turchia 180
IN - India 160
JP - Giappone 86
AR - Argentina 74
ID - Indonesia 42
MX - Messico 35
IQ - Iraq 34
BD - Bangladesh 32
EC - Ecuador 32
CA - Canada 31
CO - Colombia 25
BE - Belgio 24
ZA - Sudafrica 23
CL - Cile 18
ES - Italia 18
MA - Marocco 18
PK - Pakistan 18
PY - Paraguay 18
UZ - Uzbekistan 18
AT - Austria 17
VE - Venezuela 17
NL - Olanda 16
PE - Perù 16
IL - Israele 12
PL - Polonia 12
DZ - Algeria 11
TW - Taiwan 10
MD - Moldavia 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
EU - Europa 8
IR - Iran 8
TN - Tunisia 8
AU - Australia 7
KE - Kenya 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
MY - Malesia 6
NP - Nepal 6
AL - Albania 5
BB - Barbados 5
JM - Giamaica 5
LB - Libano 5
BG - Bulgaria 4
CH - Svizzera 4
HN - Honduras 4
TH - Thailandia 4
UY - Uruguay 4
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
AP - ???statistics.table.value.countryCode.AP??? 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
GY - Guiana 2
HR - Croazia 2
LT - Lituania 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
Totale 26.773
Salva come PNG Salva come JPEG
Città #
Dublin 1.954
Jacksonville 1.715
Hong Kong 1.469
Santa Clara 1.340
Moscow 1.288
Singapore 1.058
Chandler 756
Princeton 359
Medford 326
Seoul 257
Bremen 225
Hefei 211
Roxbury 188
Boardman 182
San Mateo 158
Ashburn 155
The Dalles 149
Beijing 146
Wilmington 139
Bengaluru 138
Ho Chi Minh City 123
Ann Arbor 102
Woodbridge 86
Hanoi 81
Cambridge 77
São Paulo 72
Des Moines 70
Dallas 60
Naples 57
Düsseldorf 49
New York 43
Caserta 42
Rio de Janeiro 38
Munich 34
Norwalk 34
Jinan 33
Shanghai 32
Rome 29
Los Angeles 24
Curitiba 23
Brussels 22
Brasília 21
Guangzhou 21
Nanjing 20
Falkenstein 19
Milan 19
Zhengzhou 19
Belo Horizonte 18
Changsha 18
Guarulhos 18
Hebei 18
Napoli 18
Tashkent 18
Nuremberg 17
Mountain View 16
Porto Alegre 16
Shenyang 16
Campinas 15
Houston 15
Redwood City 15
Salvador 15
Turku 15
Biên Hòa 14
Haiphong 14
Bari 13
Dhaka 13
Goiânia 13
Hải Dương 13
London 13
Osasco 13
Shenzhen 13
Auburn Hills 12
Baghdad 12
Haikou 12
Canoas 11
Dearborn 11
Hangzhou 11
Sorocaba 11
Caxias do Sul 10
Da Nang 10
Guayaquil 10
Lima 10
Manaus 10
Phoenix 10
Tianjin 10
Alvignano 9
Bauru 9
Casoria 9
Columbus 9
Santo André 9
Cabo Frio 8
Casablanca 8
Chisinau 8
Council Bluffs 8
Florence 8
Fortaleza 8
Johannesburg 8
Lanzhou 8
Padang 8
Seattle 8
Totale 14.105
Salva come PNG Salva come JPEG
Nome #
Farmaci dell’Apparato Respiratorio: Regolazione del tono broncomotore. 360
Sistema purinergico. 304
“COPDCoRi: applicazione non invasiva per la stima e la previsione del rischio di patologia coronarica nei pazienti affetti da broncopneumopatia cronica ostruttiva (BPCO)”. 142
Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa 141
Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure. 127
Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema 123
10. Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease. 121
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. 118
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? 112
Brain natriuretic peptide : much more than a biomarker 111
A comparison of sensory nerve function in human, guinea-pig, rabbit and marmoset airways 110
1. New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol. 109
Amminoacidi eccitatori e regolazione centrale della funzione cardiovascolare: contributi sperimentali. 109
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 109
Assessing the viability of long-acting β(2)-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective. 108
Calcium dependence of the evoked arginine vasopressin release by electrical stimulation and by L-glutamate 107
Effects of hyperbaric oxygen exposure on non-adrenergic non-cholinergic responses of rat trachea 107
Excitatory amino acids and cardiovascular apparatus: experimental studies on conscious rats with L-glutamate, N-methyl-D-aspartate, kainate and quisqualate 106
Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD. 103
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD 102
Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. 102
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease 101
Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa 100
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 99
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease 99
Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis 99
5-HT modifiers as a potential treatment of asthma 99
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement 99
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi. 98
Flomoxef, a new oxacephem antibiotic, does not cause hemostatic defects 98
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients. 97
Evidence of muscarinic receptor subtypes in airway smooth muscle of normal volunteers and of chronic obstructive pulmonary disease patients 97
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease 96
Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits 96
Research on heterocyclic compounds. XIV - Imidazothiazole and imidazobenzothiazole derivatives: synthesis and antiinflammatory activity 95
Role of 5-hydroxytryptamine in mediating adenosine-induced airway contraction 95
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways. 94
Terapie per i disordini labirintici: effetti e riflessi sulla pressione arteriosa 94
Brain Natriuretic Peptide Protects Against Hyperreactivity of Human Asthmatic Airway Smooth Muscle via an Epithelial Cell Dependent Mechanism. 93
K+ channels and guinea-pig trachea: a possible functional modulation by GABAB receptors 93
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease. 92
Prenatal and postnatal vanadium exposure in rats: effect on vasomotor reactivity development of pups 92
A review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma 92
Ions and intracellular mechanisms involved in the effects of L-glutamate on arginine vasopressin release: in vitro researches on rat neurohypophysis 91
. Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells. 91
Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD 91
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders 90
Effects of in vitro 5-HT1 receptor activation in guinea pig trachea 90
Effects of RO 5-4864 and PK 11195 on guinea pig trachea 90
[The therapeutic prospects of ischemic cardiopathy] 90
Treatment of COPD: moving beyond the lungs. 90
Protein Prenylation Contributes to the Effects of LPS on EFS-Induced Responses in Human Isolated Bronchi 90
Treating systemic effects of COPD. 89
Intraulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections. 89
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study 88
N-acetylcysteine in COPD may be beneficial, but for whom? 88
Farmaci del sistema cardiovascolare, del sangue e del rene 88
characterization of the Pharmacological interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. 87
Farmaci per il trattamento delle aritmie cardiache. 87
N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation. 87
Tremor and β(2)-adrenergic agents: is it a real clinical problem? 86
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 86
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 86
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application 85
Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease 85
Prenatal and postnatal antimony exposure in rats: effect on vasomotor reactivity development of pups 85
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 85
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma. 85
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 84
The burden of obesity in asthma and COPD: Role of adiponectin 84
Evidence for non-adrenergic non-cholinergic contractile responses in bovine and swine trachea 84
Advances in the Pharmacological Management of Pediatric Acute Respiratory Distress Syndrome 83
Pharmacological Characterization of Adenosine Receptors on Isolated Human Bronchi 82
Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler 82
Functional role of nitric oxide in guinea pig tracheal epithelium 82
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPD 82
I farmaci del sistema nervoso centrale 82
Bioavailability of timolol and aceclidine after ocular instillation in the rabbit 81
Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents 81
Nitric oxide and airways. 81
A potential role of triple therapy for asthma patients 81
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. 80
Role of 5-HT2 receptor subtypes in mediating adenosine-induced airway contraction 80
Bacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD. 80
Serum digoxin levels after concomitant ticarcillin and clavulanic acid administration 79
Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children 79
Translational Study Searching for Synergy between Glycopyrronium and Indacaterol. 79
LABAs in asthmatic children: highlights and new inside. 79
β(2) -adrenoceptor agonists: current and future direction 79
Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough 79
Possible functional modulation by acetylcholine of nitric oxide on guinea pig isolated trachea 79
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 79
Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma 78
Emerging drugs for chronic obstructive pulmonary disease 78
Farmaci per il trattamento della cardiopatia ischemica. 78
Treatment of Chronic Obstructive Pulmonary Disease by Dual Bronchodilation with Coformulation of Indacaterol/Glycopyrronium. 77
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation. 77
Nitric oxide regulatory role in sensitized guinea pig trachea 77
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach? 76
Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study 76
Totale 9.706
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.290 0 0 0 0 0 29 346 282 20 290 261 62
2021/20221.935 168 15 27 42 688 7 25 47 59 70 185 602
2022/20233.445 411 47 36 234 440 248 7 178 1.694 17 53 80
2023/20241.395 103 34 35 138 551 59 36 33 14 21 85 286
2024/20255.490 34 33 57 154 874 615 551 446 657 1.411 394 264
2025/20268.980 848 800 1.035 1.260 1.277 3.760 0 0 0 0 0 0
Totale 27.182